PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia

Umberto Campia; Linda A. Matuskey; Manfredi Tesauro; Carmine Cardillo; Julio A. Panza

doi:10.1016/j.atherosclerosis.2014.03.035

PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia

Umberto Campia, Linda A. Matuskey, Manfredi Tesauro, Carmine Cardillo, Julio A. Panza

Risultato della ricerca: Contributo in rivista › Articolo in rivista

2 Citazioni (Scopus)

Abstract

This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.

Lingua originale	English
pagine (da-a)	436-440
Numero di pagine	5
Rivista	Atherosclerosis
Volume	234
DOI	https://doi.org/10.1016/j.atherosclerosis.2014.03.035
Stato di pubblicazione	Pubblicato - 2014

Keywords

Biological Markers
C-Reactive Protein
Cross-Over Studies
District of Columbia
Double-Blind Method
Endothelial function
Endothelin A Receptor Antagonists
Endothelin activity
Endothelin-1
Endothelium, Vascular
Fatty Acids, Nonesterified
Forearm
Humans
Hypercholesterolemia
Hypertension
Insulin
Insulin Resistance
Insulin resistance
Lipoproteins, HDL
PPAR gamma
Peptides, Cyclic
Thiazolidinediones
Time Factors
Treatment Outcome
Triglycerides
Vasodilation

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.atherosclerosis.2014.03.035

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{999e88d0f36245c68af08f054c733f28,

title = "PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia",

abstract = "This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.",

keywords = "Biological Markers, C-Reactive Protein, Cross-Over Studies, District of Columbia, Double-Blind Method, Endothelial function, Endothelin A Receptor Antagonists, Endothelin activity, Endothelin-1, Endothelium, Vascular, Fatty Acids, Nonesterified, Forearm, Humans, Hypercholesterolemia, Hypertension, Insulin, Insulin Resistance, Insulin resistance, Lipoproteins, HDL, PPAR gamma, Peptides, Cyclic, Thiazolidinediones, Time Factors, Treatment Outcome, Triglycerides, Vasodilation, Biological Markers, C-Reactive Protein, Cross-Over Studies, District of Columbia, Double-Blind Method, Endothelial function, Endothelin A Receptor Antagonists, Endothelin activity, Endothelin-1, Endothelium, Vascular, Fatty Acids, Nonesterified, Forearm, Humans, Hypercholesterolemia, Hypertension, Insulin, Insulin Resistance, Insulin resistance, Lipoproteins, HDL, PPAR gamma, Peptides, Cyclic, Thiazolidinediones, Time Factors, Treatment Outcome, Triglycerides, Vasodilation",

author = "Umberto Campia and Matuskey, {Linda A.} and Manfredi Tesauro and Carmine Cardillo and Panza, {Julio A.}",

year = "2014",

doi = "10.1016/j.atherosclerosis.2014.03.035",

language = "English",

volume = "234",

pages = "436--440",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Science Ireland Limited:PO Box 85, Limerick Ireland:011 353 61 709600, 011 353 61 61944, EMAIL: [email protected], INTERNET: http://www.elsevier.com, Fax: 011 353 61 709114",

}

TY - JOUR

T1 - PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia

AU - Campia, Umberto

AU - Matuskey, Linda A.

AU - Tesauro, Manfredi

AU - Cardillo, Carmine

AU - Panza, Julio A.

PY - 2014

Y1 - 2014

N2 - This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.

AB - This study tested the hypothesis that pioglitazone reduces endothelin-1 activity in the forearm vasculature in non-diabetic patients with hypertension or hypercholesterolemia and variable degrees of insulin resistance.

KW - Biological Markers

KW - C-Reactive Protein

KW - Cross-Over Studies

KW - District of Columbia

KW - Double-Blind Method

KW - Endothelial function

KW - Endothelin A Receptor Antagonists

KW - Endothelin activity

KW - Endothelin-1

KW - Endothelium, Vascular

KW - Fatty Acids, Nonesterified

KW - Forearm

KW - Humans

KW - Hypercholesterolemia

KW - Hypertension

KW - Insulin

KW - Insulin Resistance

KW - Insulin resistance

KW - Lipoproteins, HDL

KW - PPAR gamma

KW - Peptides, Cyclic

KW - Thiazolidinediones

KW - Time Factors

KW - Treatment Outcome

KW - Triglycerides

KW - Vasodilation

KW - Biological Markers

KW - C-Reactive Protein

KW - Cross-Over Studies

KW - District of Columbia

KW - Double-Blind Method

KW - Endothelial function

KW - Endothelin A Receptor Antagonists

KW - Endothelin activity

KW - Endothelin-1

KW - Endothelium, Vascular

KW - Fatty Acids, Nonesterified

KW - Forearm

KW - Humans

KW - Hypercholesterolemia

KW - Hypertension

KW - Insulin

KW - Insulin Resistance

KW - Insulin resistance

KW - Lipoproteins, HDL

KW - PPAR gamma

KW - Peptides, Cyclic

KW - Thiazolidinediones

KW - Time Factors

KW - Treatment Outcome

KW - Triglycerides

KW - Vasodilation

UR - http://hdl.handle.net/10807/64371

U2 - 10.1016/j.atherosclerosis.2014.03.035

DO - 10.1016/j.atherosclerosis.2014.03.035

M3 - Article

SN - 0021-9150

VL - 234

SP - 436

EP - 440

JO - Atherosclerosis

JF - Atherosclerosis

ER -

PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo